Dr. Janson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
42 E Laurel Rd
Ste 1800-A
Stratford, NJ 08084Phone+1 856-566-6843Fax+1 856-566-6419
Education & Training
- University of MinnesotaResidency, Neurology, 2011 - 2014
- University of MinnesotaResidency, Neurological Surgery, 2006 - 2011
- M Health FairviewInternship, Transitional Year, 2005 - 2006
- Yale School of MedicineClass of 2001
Certifications & Licensure
- IL State Medical License 2011 - 2026
- MO State Medical License 2006 - 2025
- NJ State Medical License 2022 - 2025
- OH State Medical License 2019 - 2025
- FL State Medical License 2021 - 2024
- MN State Medical License 2014 - 2022
- ND State Medical License 2016 - 2022
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Publications & Presentations
PubMed
- 184 citationsLong-Term Follow-Up After Gene Therapy for Canavan DiseasePaola Leone, David Shera, Scott W.J. McPhee, Jeremy S. Francis, Edwin H. Kolodny
Science Translational Medicine. 2012-12-19 - 87 citationsSimultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of...Barbara Tavazzi, Giuseppe Lazzarino, Paola Leone, Angela Maria Amorini, Francesco Bellia
Clinical Biochemistry. 2005-11-01 - 145 citationsQuantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.Ruian Xu, Christopher G. Janson, Mihail Y. Mastakov, P. Lawlor, Deborah Young
Gene Therapy. 2001-09-01
Press Mentions
- Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan DiseaseFebruary 15th, 2022
- Myrtelle Announces Presentation at the 5th Annual Gene Therapy for Neurological Disorders SummitNovember 8th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: